Latest Breaking News On - Aprocitentan tryvio - Page 1 : vimarsana.com

Michael Weber, MD, lead of the PRECISION trial, discusses the significance of the aprocitentan (Tryvio) approval and key points for providers who may have patients with uncontrolled hypertension.

New yorkUnited statesAprocitentan tryvioMichael weberAblative solutionsCardiovascular medicineState universityStandard error